NDC 62541-401 – Pancreaze

Pancrelipase Lipase 2600 [USP'U]/1; Pancrelipase Amylase 15200 [USP'U]/1; Pancrelipase Protease 8800 [USP'U]/1 · Capsule, Delayed Release · Oral

Human Prescription Drug 1 recall

Product NDC62541-401

Product details

Brand name
Pancreaze
Generic name
PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
Labeler
VIVUS LLC
Dosage form
Capsule, Delayed Release
Route
Oral
Marketing category
BLA · BLA022523
Marketed since
August 1, 2016
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Pancreaze →

Package NDC codes (1)

Package NDCDescriptionSince
62541-401-101 BOTTLE, GLASS in 1 CARTON (62541-401-10) / 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASSAug 1, 2016

Recalls mentioning this NDC

Other Pancreaze products